Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2008-06-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2008.05.003PMID 18501613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.

  2008cited by this paper
• Butyl 2-(4-[1.1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain.

  2007cited by this paper
• Voltage-gated Na+ channels in neuropathic pain

  2007cited by this paper
• New treatments for acute humoral rejection of kidney allografts

  2007cited by this paper
• Sodium channel blockers.

  2007cited by this paper
• A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

  2007cited by this paper
• Animal models of pain for drug discovery

  2006cited by this paper
• Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.

  2006cited by this paper
• Novel Sodium Channel Blockers for the Treatment of Neuropathic Pain

  2006cited by this paper
• New targets for neuropathic pain therapeutics

  2005cited by this paper
• Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior.

  2005cited by this paper
• Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats

  2005cited by this paper
• Discovery of potent and use-dependent sodium channel blockers for treatment of chronic pain.

  2005cited by this paper
• Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.

  2004cited by this paper
• Differential expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 in normal and inflamed rats.

  2004cited by this paper
• The role of voltage-gated sodium channels in neuropathic pain.

  2003cited by this paper
• Inhibition of neuropathic pain by decreased expression of the tetrodotoxin‐resistant sodium channel, NaV1.8

  2002cited by this paper
• A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

  2002cited by this paper
• Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons.

  2001cited by this paper
• Medicinal chemistry of neuronal voltage-gated sodium channel blockers.

  2001cited by this paper
• From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.

  2000cited by this paper
• Nomenclature of voltage-gated sodium channels.

  2000cited by this paper
• The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways

  1999cited by this paper
• Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain

  1999cited by this paper
• An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

  1992cited by this paper
• Screening for potassium channel modulators by a high through-put 86-rubidium efflux assay in a 96-well microtiter plate.

  1991cited by this paper
• Pharmacology and biochemistry of some amphenone analogues and other adrenal cortical inhibitors.

  1959cited by this paper

• Functional Coupling Between Voltage-Dependent Sodium Channels and Activation of the Ca2+ Signaling That Mediates Endothelial Cell Migration.

  2026cites this paper
• Brief analysis of Nav1.7 inhibitors: Mechanism of action and new research trends.

  2025cites this paper
• In Silico Screening Identification of Fatty Acids and Fatty Acid Derivatives with Antiseizure Activity: In Vitro and In Vivo Validation

  2024cites this paper
• Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII.

  2021cites this paper
• A Review: Medicinally Important Nitrogen Sulphur Containing Heterocycles

  2020cites this paper
• Synthesis of Symmetrical N-(Het)aryl-C-phosphonoacetamidines

  2019cites this paper
• Sodium Channel Blockers for the Treatment of Pain

  2017cites this paper
• What is an "ideal" antibiotic? Discovery challenges and path forward.

  2017cites this paper
• Isoform selective voltage-gated sodium channel modulators and the therapy of pain.

  2013cites this paper
• Klatrodiinin analogit jänniteherkkien natriumkanavien salpaajina

  2013cites this paper
• Differential sensitivities of the vascular K(ATP) channel to various PPAR activators.

  2013cites this paper
• HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats.

  2012cites this paper
• Neurological perspectives on voltage-gated sodium channels

  2012influential citation
• Synthesis and antimicrobial activity of morpholinyl/piperazinylbenzothiazines

  2012cites this paper
• Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus

  2012influential citation
• Synthesis of skeletal analogues of saxitoxin derivatives and evaluation of their inhibitory activity on sodium ion channels Na(V)1.4 and Na(V)1.5.

  2011cites this paper
• Design, Synthesis and Biological Activity Evaluation of Arylpiperazine Derivatives for the Treatment of Neuropathic Pain

  2011cites this paper
• Evaluation of anticonvulsants for possible use in neuropathic pain.

  2011cites this paper
• Discovery of molecules for the treatment of neuropathic pain: synthesis, antiallodynic and antihyperalgesic activities of 5-(4-nitrophenyl)furoic-2-acid hydrazones.

  2011cites this paper
• Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.

  2011cites this paper
• Isoform-selective voltage-gated Na(+) channel modulators as next-generation analgesics.

  2010cites this paper
• Voltage Gated Sodium Channel Blockers: Potential Treatment for Neuropathic Pain

  2010cites this paper
• Subtype‐selective targeting of voltage‐gated sodium channels

  2009cites this paper
• Recent advances in the medicinal chemistry of sodium channel blockers and their therapeutic potential.

  2009cites this paper
• Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer.

  2009cites this paper
• Voltage-gated sodium channel blockers for the treatment of chronic pain.

  2009cites this paper
• Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones.

  2009cites this paper
• Voltage-gated sodium channels: the search for subtype-selective analgesics

  2008cites this paper